Text Size

Right Ventricular Hypertrophy and Pulmonary Hypertension: A Correlation Analysis

This study has been completed.
Sponsor:
Information provided by:
University of Cincinnati
ClinicalTrials.gov Identifier:
NCT00875940
First received: April 3, 2009
Last updated: NA
Last verified: April 2009
History: No changes posted
  Purpose

The study hypothesis is that a quantitative index can be derived from Tc-99m myocardial perfusion scans that accurately identifies the presence of left ventricular hypertrophy and pulmonary hypertension. Echocardiography provides the reference standard.


Condition Intervention
Pulmonary Hypertension
 Other: Diagnostic imaging procedures.

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Right Ventricular Hypertrophy and Pulmonary Hypertension: A Correlation Analysis Between Tc-99m Tetrofosmin SPECT Adn Echocardiography

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University of Cincinnati:

Primary Outcome Measures:
  • Sensitivity and specificity of quantitation of Tc-99m perfusion scans for identification of pulmonary hypertension. [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Study Start Date: February 2008
Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Group 1
Patients having both Tc-99m perfusion scan and echocardiogram.
 Other: Diagnostic imaging procedures.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Hospital population having diagnostic testing.

Criteria

Inclusion Criteria:

  • Must have an interpretable Tc-99m myocardial perfusion scan and an interpretable echocardiogram.

Exclusion Criteria:

  • Technically inadequate noninvasive test.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00875940

Locations
United States, Ohio
University of Cincinnati
Cincinnati, Ohio, United States, 45267
Sponsors and Collaborators
University of Cincinnati
  More Information

No publications provided

Responsible Party: Myron Gerson M.D., University Internal Medicine Associates
ClinicalTrials.gov Identifier: NCT00875940     History of Changes
Other Study ID Numbers: IRB # 08-01-24-02
Study First Received: April 3, 2009
Last Updated: April 3, 2009
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Hypertension
Hypertension, Pulmonary
Hypertrophy
Hypertrophy, Right Ventricular
Vascular Diseases
Cardiovascular Diseases
 Lung Diseases
Respiratory Tract Diseases
Pathological Conditions, Anatomical
Cardiomegaly
Heart Diseases

ClinicalTrials.gov processed this record on May 16, 2013